PL2988782T3 - Postacie dawkowania do podawania substancji czynnych drogą doustną - Google Patents

Postacie dawkowania do podawania substancji czynnych drogą doustną

Info

Publication number
PL2988782T3
PL2988782T3 PL14731011T PL14731011T PL2988782T3 PL 2988782 T3 PL2988782 T3 PL 2988782T3 PL 14731011 T PL14731011 T PL 14731011T PL 14731011 T PL14731011 T PL 14731011T PL 2988782 T3 PL2988782 T3 PL 2988782T3
Authority
PL
Poland
Prior art keywords
dosage forms
oral administration
active substances
substances
active
Prior art date
Application number
PL14731011T
Other languages
English (en)
Inventor
Giammaria Giuliani
Anna Benedusi
Antonio Mascolo
Antonio LIMITONE
Original Assignee
Giuliani S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Giuliani S.P.A. filed Critical Giuliani S.P.A.
Publication of PL2988782T3 publication Critical patent/PL2988782T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL14731011T 2013-04-24 2014-04-22 Postacie dawkowania do podawania substancji czynnych drogą doustną PL2988782T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT000682A ITMI20130682A1 (it) 2013-04-24 2013-04-24 Forme di dosaggio per la somministrazione orale di sostanze attive
EP14731011.4A EP2988782B1 (en) 2013-04-24 2014-04-22 Dosage forms for oral administration of active substances
PCT/IB2014/060892 WO2014174430A1 (en) 2013-04-24 2014-04-22 Dosage forms for oral administration of active substances

Publications (1)

Publication Number Publication Date
PL2988782T3 true PL2988782T3 (pl) 2019-12-31

Family

ID=48748359

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14731011T PL2988782T3 (pl) 2013-04-24 2014-04-22 Postacie dawkowania do podawania substancji czynnych drogą doustną

Country Status (17)

Country Link
US (1) US20160081935A1 (pl)
EP (1) EP2988782B1 (pl)
CA (1) CA2910354C (pl)
CY (1) CY1122160T1 (pl)
DK (1) DK2988782T3 (pl)
ES (1) ES2741501T3 (pl)
HR (1) HRP20191493T1 (pl)
HU (1) HUE044668T2 (pl)
IT (1) ITMI20130682A1 (pl)
LT (1) LT2988782T (pl)
PL (1) PL2988782T3 (pl)
PT (1) PT2988782T (pl)
RS (1) RS59133B1 (pl)
SI (1) SI2988782T1 (pl)
SM (1) SMT201900538T1 (pl)
TR (1) TR201910708T4 (pl)
WO (1) WO2014174430A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10030022B2 (en) * 2015-03-20 2018-07-24 Elc Management Llc Method of stabilizing riboflavin

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6319510B1 (en) * 1999-04-20 2001-11-20 Alayne Yates Gum pad for delivery of medication to mucosal tissues
JP2004525110A (ja) * 2001-02-16 2004-08-19 清水製薬株式会社 ムコ多糖類製剤およびその製造法
US20020172712A1 (en) * 2001-03-19 2002-11-21 Alan Drizen Antiemetic, anti-motion sustained release drug delivery system
US7767806B2 (en) * 2003-09-08 2010-08-03 Chugai Seiyaku Kabushiki Kaisha Hyaluronic acid modification products and drug carriers using them
WO2005105036A1 (en) * 2004-04-28 2005-11-10 Natco Pharma Limited Controlled release mucoadhesive matrix formulation containing tolterodine and a process for its preparation
ITMI20050262A1 (it) * 2005-02-21 2006-08-22 Carlo Ghisalberti Sostanze composizioni e metodi di trattamento dell'alopecia
US20100098794A1 (en) * 2008-10-17 2010-04-22 Armand Gerard Topical anti-wrinkle and anti-aging moisturizing cream

Also Published As

Publication number Publication date
EP2988782B1 (en) 2019-05-22
CY1122160T1 (el) 2020-11-25
SI2988782T1 (sl) 2019-09-30
ITMI20130682A1 (it) 2014-10-25
LT2988782T (lt) 2019-08-12
SMT201900538T1 (it) 2019-11-13
CA2910354A1 (en) 2014-10-30
HUE044668T2 (hu) 2019-11-28
US20160081935A1 (en) 2016-03-24
RS59133B1 (sr) 2019-09-30
WO2014174430A1 (en) 2014-10-30
DK2988782T3 (da) 2019-07-29
PT2988782T (pt) 2019-09-10
TR201910708T4 (tr) 2019-08-21
EP2988782A1 (en) 2016-03-02
HRP20191493T1 (hr) 2019-11-15
CA2910354C (en) 2021-04-27
ES2741501T3 (es) 2020-02-11

Similar Documents

Publication Publication Date Title
IL283032A (en) Preparations for oral administration of tofacitinib
PL2968071T3 (pl) Urządzenie do doustnego dostarczania związków leczniczych
PT3157508T (pt) Forma de dosagem oral sólida de compostos lipofílicos
EP2950809A4 (en) PHARMACEUTICAL COMPOSITIONS FOR THE ORAL TREATMENT OF DIABETES
ZA201509239B (en) Amorphous letermovir and solid pharmaceutical formulations thereof for oral administration
EP3038465A4 (en) Oral pharmaceutical formulation of omarigliptin
IL241917B (en) Formulations for subcutaneous administration of furosemide
PT2968368T (pt) Administração craniana de substâncias farmacêuticas
ZA201405797B (en) Pharmaceutical dosage form
DK2964193T3 (da) Lægemidler til oral indgivelse
IL245705A0 (en) Pharmaceutical dosage forms
EP2958593A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TRANSMUCOSAL ADMINISTRATION OF BENZODIAZEPINES
GB201305103D0 (en) An oral dosage form
EP2979698A4 (en) PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
SI2988782T1 (sl) Odmerne oblike za peroralno dajanje učinkovin
IL240119A0 (en) Pharmaceutical compositions for oral treatment of diabetes
ITMI20120350A1 (it) Forma di dosaggio per somministrazione orale di principi attivi
ZA201502354B (en) Pharmaceutical dosage form